StockData
Regentis Biomaterials Ltd. logo

Regentis Biomaterials Ltd. (RGNT) stock

RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 24, 2026Score 1/30
$1.14−0.08 (-6.56%)

Close on Nov 18, 2026Market cap $5.90MP/E –Yield –

Regentis Biomaterials operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -$1.38M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$1.38M–
FY2024Dec 31, 2024-$641.00K–
FY2023Dec 31, 2023-$1.22M–

More Regentis Biomaterials figures

See a number that looks wrong?